AKT1 and acute lymphoblastic leukemia: In conclusion, the comprehensive pharmacological evaluation of NSp‐B in its complex with AKT reveals promising attributes for potential therapeutic applications in T‐ALL and provides a strong foundation for further exploration of its therapeutic potential.